GE Healthcare Korea said UGAP (Ultrasound-Guided Attenuation Parameter), which can quantitatively scan for hepatic steatosis of non-alcoholic fatty liver disease (NAFLD) using B-mode ultrasound attenuation coefficient, was recognized by the government as newmedical technology.UGAP makes quantitative
Dx&Vx said it acquired Korea Bio Pharm for 15 billion won ($10.7 million) to begin the contract development and manufacturing organization (CDMO) business.Korea Bio Pharm, established in 1995 and located in Jincheon, North Chungcheong Province, is a health functional food manufacturer of 120 product
Korea is often called “a society of distrust” or “a society of conflicts.” Distrust runs deep in existing systems including the state, media, business, and civic groups. Accordingly, social conflicts occur frequently across the boundaries of political ideologies, regions, and generations. Recent con
Korea received the first batch of Moderna's bivalent vaccine, a vaccine developed to fight Omicron subvariants, on Thursday.According to the Korea Disease Control and Prevention Agency (KDCA), Korea has received 805,000 out of the 1.61 million doses planned for introduction via Incheon International
Cash reserves of Korean biopharmaceutical companies are shrinking, causing concerns that several companies may go bankrupt in the worst-case scenario.According to industry watchers, Korean biopharmaceutical companies are facing headwinds in attracting investments because the financial markets nearly
Voronoi and U.S. bio company METiS Therapeutic have signed a contract to license out (L/O) kinase inhibitor technology worth 668 billion won ($482 million).In a public notice Wednesday, Voronoi said it had signed a technology transfer contract for phosphorylase inhibitors for oral use (kinase) for t
Dong-A ST said it signed a global licensing agreement with NeuroBo Pharmaceuticals, a U.S. pharmaceutical company.Under the accord, Dong-A ST plans to accelerate the global development and commercialization of DA-1241, a type 2 diabetes and nonalcoholic steatohepatitis (NASH) treatment, and DA-1726,
Daehwa Pharmaceutical said Wednesday that it had been notified of the acceptance of the application for new drug approval for Liporaxel/RMX3001, oral paclitaxel (DHP107/RMX3001) drug, from China’s National Medical Products Administration.The indication of Liporaxel/RMX3001 seeking the Chinese permit
Asan Medical Center (AMC), located in Seoul, said it ranked within the world’s top 10 hospitals in five specialties out of the total 11 specialties in Newsweek’s World’s Best Specialized Hospitals 2023.Specifically, AMC was the world’s No. 3 hospital in endocrinology, No. 4 in urology, No. 6 in gast
Korean physicians expressed their high expectations for SpaceOAR, Boston Scientific's new medical device that reduces side effects in radiation therapy for prostate cancer patients.SpaceOAR device reduces the amount of radiation delivered to the rectum by injecting a hydrogel barrier between the pro
PARIS -- “Lung cancer treatment is developing day by day, but the domestic health insurance benefits and other treatment environments fall far short of supporting the development.”Professor Ahn Myung-joo of the Department of Hemato-oncology at Samsung Medical Center (SMC) said so on Sunday when aske
Lilly Korea said it released Retevmo (selpercatinib), the first RET (rearranged during transfection) targeted therapy, in Korea on Wednesday.The market release follows Retevmo’s winning the regulatory nod in March to treat adult patients with metastatic RET fusion-positive non-small cell lung cancer
Citizens can receive the Covid-19 and influenza vaccination simultaneously on each arm, a top quarantine advisor said."This is because the side effects are similar to receiving the two vaccines individually, and most of the people have already received a Covid-19 vaccine at least once," said Jung Ki
The Ministry of Food and Drug Safety has added tumor lysis syndrome (TLS) to the adverse effects of sorafenib-based treatments for liver cancer.On Tuesday, the Drug Safety Assessment Division of the ministry made public changes in permitted contents – directions for use of medicine – of sorafenib dr
Qurient said it entered into a joint development agreement with MSD (Merck in the U.S.) for clinical research on the combination therapy of Q901, a selective CDK7 inhibitor, and MSD’s Keytruda, an anti-programmed cell death protein1 (PD-1) immunotherapy.Under the accord, the two companies will condu
As the government moves toward allowing the publication of non-paid medical expense information by one-line platforms, such as “Gangnam Sister," plastic surgeons opposed the move, saying it would allow patient solicitation and lower medical quality.On Sept. 5, the government held an online meeting o
Over the past 10 years, the overall death rate in Seoul continued to decline but pneumonia deaths, one of the key health indicators, rather increased, a government report showed.The Seoul Health Foundation (SHF), run under the Seoul Metropolitan Government, released a report analyzing changes in the
A joint research team, consisting of researchers from Yonsei University College of Medicine and Severance Hospital, has developed a therapeutic agent that increases the efficacy of glioblastoma (GBM) anticancer drugs by 136 percent.GBM is a cancer that occurs in nerve cells in the brain. The cancer
Amid the prolonged Covid-19 pandemic, the discussion on how to distribute limited medical resources has emerged as a global topic. In the U.K. in particular, interest is growing in people with developmental disabilities placed in the blind spots of healthcare and welfare, although they account for o
MedPacto said Tuesday that it has presented a poster study on the interim clinical data of the Vactosertib combination therapy related to pancreatic cancer during the American Association for Cancer Research (AACR) Special Conference on Pancreatic Cancer.The study is an investigator-initiated clinic